Spectrum Pharmaceuticals, Inc. Shares Fall 0.8% Below Previous 52-Week Low - Market Mover
The shares fell 0.8% lower than its previous 52-week low of $1.23, with trading volume higher than its 30 day average
Jan 07, 2022 by Kwhen Finance Editors
Spectrum Pharmaceuticals, Inc. (SPPI) shares closed 0.8% lower than its previous 52 week low, giving the company a market cap of $208M. The stock is currently flat year-to-date, down 63.5% over the past 12 months, and down 73.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 1.9%.
Trading Activity
- Trading volume this week was 53.5% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.6.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Spectrum Pharmaceuticals, Inc. | -3.9 | 0.0 | -63.5 | -71.6 | 4.9 |
| Dow Jones Industrial Average | -0.5 | 0.2 | 21.9 | -1.4 | 24.0 |
| S&P 500 Index | -0.1 | -1.4 | 27.8 | -2.5 | 28.8 |
| Health Care | -1.1 | -3.5 | 19.1 | -4.6 | 22.5 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by -100.0%
- The company's stock price performance over the past 12 months lags the peer average by -2385.8%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Spectrum Pharmaceuticals, Inc. | SPPI | 0 | 0 | -63.5 | -71.6 | 4.9 |
| Peer Avg | N/A | 4.7 | -1.1 | 2.8 | -22.4 | 21.4 |
| Johnson & Johnson | JNJ | 25.4 | 0.7 | 11.5 | -3.2 | 15.8 |
| Pfizer Inc. | PFE | 16.3 | -5.8 | 55.4 | -10.6 | 70.0 |
| Abbott Laboratories | ABT | 33.0 | -4.0 | 24.3 | -5.3 | 29.1 |
| Novartis AG - ADR | NVS | 37.2 | 0.6 | -3.2 | -6.8 | 11.8 |
| Bristol-Myers Squibb Co. | BMY | -25.3 | -0.3 | 3.4 | -10.0 | 17.0 |
| Glaxosmithkline plc - ADR | GSK | 16.9 | -1.1 | 22.4 | -2.3 | 35.0 |
| Biogen Inc | BIIB | 22.7 | -0.3 | -2.9 | -48.7 | 8.4 |
| Seagen Inc | SGEN | -80.0 | -5.8 | -13.8 | -27.2 | 8.8 |
| Teva- Pharmaceutical Industries Ltd. - ADR | TEVA | 12.6 | 3.6 | -23.6 | -36.8 | 8.8 |
| Curis Inc | CRIS | -11.2 | 1.5 | -45.6 | -72.9 | 9.5 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: